Effect of sweet violet flower in the treatment of atopic dermatitis in adults
Phase 1
- Conditions
- Atopic dermatitis.Atopic dermatitis, unspecified
- Registration Number
- IRCT201606143922N3
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
acute, subacute and chronic atopic eczema with mild to moderate severity; patients older than 12 years. Exclusion criteria: pregnancy; lactation; other types of dermatitis other than atopic dermatitis; psoriasis; atopic dermatitis with severe severity.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Type of eczema. Timepoint: the first day of the study. Method of measurement: questionnaire.;Severity of eczema. Timepoint: the first day of the study, 14th day. Method of measurement: questionnaire.;Score of the disease. Timepoint: the first day of the study, 14th day. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: during the study. Method of measurement: questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of Viola odorata flowers may influence Th2/Th17 pathways in atopic dermatitis?
How does Viola odorata compare to dupilumab in Phase I trials for atopic dermatitis efficacy and safety?
Which biomarkers (e.g., filaggrin, IgE) predict response to Viola odorata treatment in adult AD patients?
What are the potential adverse events of Viola odorata topical application in Phase I AD trials?
Are there synergistic effects of combining Viola odorata with corticosteroids or other natural extracts for AD?